Shrisha Maskey
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
-
- Long-Term Effects of COVID-19 1
- Journals
- Nature Medicine (2 papers)Nature (1 paper)Cancer Discovery (1 paper)Nature Communications (1 paper)Clinical Proteomics (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Shrisha Maskey
6 papers receiving 1k citations
Shrisha Maskey's Hit Papers
Peers
Comparison fields: 5 of 63
- Immunology 438
- Oncology 446
- Molecular Biology 179
- Cancer Research 34
- Neurology 35
Countries citing papers authored by Shrisha Maskey
This map shows the geographic impact of Shrisha Maskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrisha Maskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrisha Maskey more than expected).
Fields of papers citing papers by Shrisha Maskey
This network shows the impact of papers produced by Shrisha Maskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrisha Maskey. The network helps show where Shrisha Maskey may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A conserved dendritic-cell regulatory program limits antitumour immunity Hit paper breakdown → | 2020 | 690 |
| 2 | Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors Hit paper breakdown → | 2022 | 249 |
| 3 | 2021 | 51 | |
| 4 | 2022 | 48 | |
| 5 | 2020 | 16 | |
| 6 | 2022 | 5 |
About Shrisha Maskey
Shrisha Maskey is a scholar working on Infectious Diseases, Neurology, Immunology, Oncology and Surgery, having authored 6 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Cells and Metastasis (1 paper), Immunotherapy and Immune Responses (1 paper), Single-cell and spatial transcriptomics (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Kawasaki Disease and Coronary Complications (1 paper) and Long-Term Effects of COVID-19 (1 paper). The work is most often cited by research in Immunology (438 citations), Oncology (446 citations), Molecular Biology (179 citations), Cancer Research (34 citations) and Neurology (35 citations). Shrisha Maskey has collaborated with scholars based in United States, Canada and Switzerland. Their work appears in journals such as Nature Medicine, Nature, Cancer Discovery, Nature Communications and Clinical Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.